Nathaniel Lacktman

Nov 17, 2024 | mondaq.com | Nathaniel Lacktman

In the wake of the U.S. Drug Enforcement Agency's (DEA) notice of a forthcoming proposed rule with a third extension of flexibilities related to telemedicine prescribing of controlled substances, some industry stakeholders anticipate the rule will extend the current DEA telemedicine prescribing flexibilities for at least another year to avoid the Telehealth Cliff. However, the proposed rule has not yet been made public and significant questions remain as to the rule's specifics.

Nov 15, 2024 | jdsupra.com | Nathaniel Lacktman

In the wake of the U.S. Drug Enforcement Agency’s (DEA) notice of a forthcoming proposed rule with a third extension of flexibilities related to telemedicine prescribing of controlled substances, some industry stakeholders anticipate the rule will extend the current DEA telemedicine prescribing flexibilities for at least another year to avoid the Telehealth Cliff. However, the proposed rule has not yet been made public and significant questions remain as to the rule’s specifics.

Nov 14, 2024 | natlawreview.com | Nathaniel Lacktman

In the wake of the U.S. Drug Enforcement Agency’s (DEA) notice of a forthcoming proposed rule with a third extension of flexibilities related to telemedicine prescribing of controlled substances, some industry stakeholders anticipate the rule will extend the current DEA telemedicine prescribing flexibilities for at least another year to avoid the Telehealth Cliff. However, the proposed rule has not yet been made public and significant questions remain as to the rule’s specifics.

Oct 17, 2024 | natlawreview.com | Faisal Ramzan |Alice Dawson-Loynes |Nathaniel Lacktman |Whitt Steineker

October 17, 2024, is the final day for European Union (“EU”) Member States to implement the necessary measures for transposing the EU Directive on measures for a high common level of cybersecurity across the EU (the “NIS2 Directive”) into their national laws. The rules of the NIS2 Directive will then become applicable from October 18, 2024, onwards.

Oct 17, 2024 | natlawreview.com | Nathaniel Lacktman

After considerable pressure from both Congress and the White House, the Drug Enforcement Administration (DEA) submitted a proposed rule regarding flexibilities on telemedicine prescribing of controlled substances on October 11, 2024. Specifics of the proposed rule are not yet available, but we anticipate the rule will extend the current DEA telemedicine prescribing flexibilities for at least one more year, possibly two.